Why does breast cancer treatment fail for so many? New study offers clues

Mar 4, 2025 | 21:09 IST

Illustration: AI

Nearly half of those with a form of breast cancer see the disease return post-treatment. A new study explains why this happens and how relapses could be prevented by junking the one-treatment-fits-all approach

Estrogen receptor-positive (ER+) breast cancer is one of the most prevalent forms of breast cancer and there is a set protocol for its treatment. However, nearly 50% of patients with this form of cancer in India either don’t respond to treatment or suffer a relapse.

A new study by scientists from the Tata Memorial Centre (TMC) in Mumbai and the National Institute of Biomedical Genomics (NIBMG) in West Bengal may finally have figured out why this happens.

TOI

TOI

Why does breast cancer treatment fail for so many? New study offers clues

Nearly half of those with a form of breast cancer see the disease return post-treatment. A new study explains why this happens and how relapses could be prevented by junking the one-treatment-fits-all approach

{{{h1}}}

{{{h1}}}

{{{h3}}}

{{{offerprice}}}

{{{h3}}}

{{{offerprice}}}

{{{h1}}}

{{{h1}}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

Your Privacy is Important to us

Opt out of the sale or sharing of personal information

TOI

Why does breast cancer treatment fail for so many? New study offers clues

Nearly half of those with a form of breast cancer see the disease return post-treatment. A new study explains why this happens and how relapses could be prevented by junking the one-treatment-fits-all approach

{{{h1}}}

{{{h1}}}

{{{h3}}}

{{{offerprice}}}

{{{h3}}}

{{{offerprice}}}

{{{h1}}}

{{{h1}}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}